Skip to content

NEUROPATHIX, INC.

company.status.inactive

CIK 1615999fmd_15J4EH83QX7R80E2R0BHEMZAFFManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2015 to Mar 31, 2022, 28 periods

Loading

Latest annual · FY2021

Millions
Total revenues
0
Gross profit
0
Operating income
(3)
Net income
(4)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
+1.8%
Revenue, 5 yearsFY2016 to FY2021
+39.3%
Net income, 5 yearsFY2016 to FY2021
n/m

NEUROPATHIX, INC. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$183,477$010-K 2022-04-15 · proof
Operating income-$2.9 million-$4.5 million10-K 2022-04-15 · proof
Net income-$3.6 million-$4.5 million10-K 2022-04-15 · proof
What was NEUROPATHIX, INC.'s revenue in fiscal 2021?
NEUROPATHIX, INC. reported revenue of $183,477 for fiscal 2021 (the year ended Dec 31, 2021), against $0 the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
What was NEUROPATHIX, INC.'s operating income in fiscal 2021?
NEUROPATHIX, INC. reported operating income of -$2.9 million for fiscal 2021 (the year ended Dec 31, 2021), against -$4.5 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
What was NEUROPATHIX, INC.'s net income in fiscal 2021?
NEUROPATHIX, INC. reported net income of -$3.6 million for fiscal 2021 (the year ended Dec 31, 2021), against -$4.5 million the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1615999&period_type=annual&limit=5"

Information only, not investment advice.